Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA GAMMA BUTYROLACTONE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 GRADE LIFE LINE CURVE
2.7 MULTIVARIATE MODELING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END-USE COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 DBMR VENDOR SHARE ANALYSIS
2.13 IMPORT-EXPORT DATA
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 LEGAL FACTORS
4.1.6 ENVIRONMENTAL FACTORS
4.2 PORTER'S FIVE FORCES:
4.2.1 THREAT OF NEW ENTRANTS:
4.2.2 THREAT OF SUBSTITUTES:
4.2.3 CUSTOMER BARGAINING POWER:
4.2.4 SUPPLIER BARGAINING POWER:
4.2.5 INTERNAL COMPETITION (RIVALRY):
4.3 CLIMATE CHANGE SCENARIO
4.3.1 ENVIRONMENTAL CONCERNS
4.3.2 INDUSTRY RESPONSE
4.3.3 GOVERNMENT'S ROLE
4.3.4 ANALYST RECOMMENDATION
4.4 LIST OF KEY PATENTS LAUNCHED
4.5 SUPPLY CHAIN ANALYSIS
4.5.1 OVERVIEW
4.5.2 LOGISTIC COST SCENARIO
4.5.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.6 VENDOR SELECTION CRITERIA
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING APPLICATION OF DERIVED CHEMICAL PRODUCTS
5.1.2 APPLICATION IN A WIDE RANGE OF INDUSTRIES
5.1.3 INCREASED DEMAND FOR ELECTRONIC ITEMS
5.2 RESTRAINTS
5.2.1 SERIOUS HEALTH EFFECTS AND SAFETY CONCERNS
5.2.2 STRINGENT RULES AND REGULATIONS
5.3 OPPORTUNITIES
5.3.1 RISE IN DEMAND FOR ELECTRIC VEHICLES
5.3.2 INCREASE IN USAGE OF ORGANIC AGROCHEMICALS
5.4 CHALLENGES
5.4.1 GOVERNMENT RESTRICTIONS FOR ILLEGAL USAGE
6 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY GRADE
6.1 OVERVIEW
6.2 INDUSTRIAL CLASS (5 WT.%)
6.3 ELECTRIC CAPACITANCE CLASS (9 WT.%)
6.4 COMMON CLASS (8 WT.%)
7 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY PURITY
7.1 OVERVIEW
7.2 MIN. 99.9%
7.3 MIN. 99.7%
8 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 SOLVENT
8.3 CASTING BINDER
8.4 HERBICIDES AND INSECTICIDES
8.5 BATTERIES AND CAPACITORS
8.6 PAINT STRIPPERS
8.7 POLISH REMOVERS
8.8 ANESTHETIC
8.9 SEDATIVE
8.1 OTHERS
9 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY END-USE
9.1 OVERVIEW
9.2 PHARMACEUTICAL INDUSTRY
9.3 ELECTRICAL INDUSTRY
9.4 AGROCHEMICAL INDUSTRY
9.5 PETROLEUM INDUSTRY
9.6 FOOD INDUSTRY
9.7 OTHERS
10 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY REGION
10.1 NORTH AMERICA
10.1.1 U.S.
10.1.2 CANADA
10.1.3 MEXICO
11 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.2 RECOGNITION
11.3 AWARD
11.4 EVENT
11.5 EXPANSION
11.6 AGREEMENT
12 SWOT ANALYSIS
13 COMPANY PROFILES
13.1 MITSUBISHI CHEMICAL CORPORATION.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 BASF SE
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENT
13.3 SIPCHEM COMPANY
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 BALAJI AMINES
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 ASHLAND
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENT
13.6 BIOSYNTH
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 BOAI NKY PHARMACEUTICALS LTD.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 BYN CHEMICALS CO., LTD
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 DCC
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENT
13.1 ZHEJIANG REALSUN CHEMICAL CO.,LTD.
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Table
TABLE 1 IMPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND)
TABLE 2 EXPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND)
TABLE 3 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 4 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 5 NORTH AMERICA INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 6 NORTH AMERICA INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS)
TABLE 7 NORTH AMERICA ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 8 NORTH AMERICA ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS)
TABLE 9 NORTH AMERICA COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 10 NORTH AMERICA COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS)
TABLE 11 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 12 NORTH AMERICA MIN. 99.9% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 13 NORTH AMERICA MIN. 99.7% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 14 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 15 NORTH AMERICA SOLVENT IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 16 NORTH AMERICA CASTING BINDER IN NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 17 NORTH AMERICA HERBICIDES AND INSECTICIDES IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 18 NORTH AMERICA BATTERIES AND CAPACITORS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 19 NORTH AMERICA PAINT STRIPPERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 20 NORTH AMERICA POLISH REMOVERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 21 NORTH AMERICA ANESTHETIC IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 22 NORTH AMERICA SEDATIVE IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 23 NORTH AMERICA OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 24 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 25 NORTH AMERICA PHARMACEUTICAL INDUSTRY IN NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 26 NORTH AMERICA ELECTRICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 27 NORTH AMERICA AGROCHEMICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 28 NORTH AMERICA PETROLEUM INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 29 NORTH AMERICA FOOD INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 30 NORTH AMERICA OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 31 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (USD THOUSAND)
TABLE 32 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (TONS)
TABLE 33 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 34 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 35 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 36 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 37 NORTH AMERICA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 38 U.S. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 39 U.S. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 40 U.S. GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 41 U.S. GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 42 U.S. GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 43 CANADA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 44 CANADA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 45 CANADA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 46 CANADA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 47 CANADA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 48 MEXICO GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 49 MEXICO GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 50 MEXICO GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 51 MEXICO GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 52 MEXICO GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA GAMMA BUTYROLACTONE MARKET
FIGURE 2 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: THE GRADE LIFE LINE CURVE
FIGURE 7 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: MARKET END-USE COVERAGE GRID
FIGURE 11 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 12 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: VENDOR SHARE ANALYSIS
FIGURE 13 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: SEGMENTATION
FIGURE 14 GROWING APPLICATION OF DERIVED CHEMICAL PRODUCTS IS EXPECTED TO DRIVE THE NORTH AMERICA GAMMA BUTYROLACTONE MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 15 INDUSTRIAL CLASS (5 WT. %) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA GAMMA BUTYROLACTONE MARKET IN 2022 & 2029
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF THE NORTH AMERICA GAMMA BUTYROLACTONE MARKET
FIGURE 17 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY GRADE, 2022
FIGURE 18 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY PURITY, 2022
FIGURE 19 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY APPLICATION, 2022
FIGURE 20 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY END-USE, 2022
FIGURE 21 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: SNAPSHOT (2022)
FIGURE 22 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY COUNTRY (2022)
FIGURE 23 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 24 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 25 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: BY GRADE (2023 - 2030)
FIGURE 26 NORTH AMERICA GAMMA BUTYROLACTONE MARKET: COMPANY SHARE 2022 (%)
